www.contrarianinvestoruk.squarespace.com
This is a work in progress, new content being added.
Contrarian Investor UK invests mainly in UK FTSE and AIM listed shares. Like famous contrarians, Warren Buffett and Anthony Bolton, he likes to take a different view to the crowd of investors. He prefers the short term, possibly speculative trade, to the long term hold and takes the view that it's about "buy and research" not "buy and hold"! This blog tracks Contrarian Investor UK's thoughts on the stockmarket and his portfolio's trades. Move against the herd with the Contrarian Investor UK!
On Monday Greece's sovereign credit rating was downgraded again by Moody’s. 2-year bonds now yield over 15 per cent and the national debt now stands at 150 per cent of GDP (gross domestic product).
So bond investors are betting that a Greek debt restructuring is inevitable. If the German and French goverments do not support this, a Greek sovereign debt default looks a certainty. Voters in these countries are unlikely to support a give away to the Greeks, so political will is not in Greece's favour. Ireland's new government is trying to renegotiate the terms of its €80 billion bail out, whether it succeeds is a matter of debate.
With €325bn of government debt outstanding at the end of 2010, Greek and other eurozone banks hold €120bn of this. Potentially a catastrophic exposure should a default ever occur.
The FTSE 100 moved into negative territory late on in the day finishing down 16 at 5,974 as Wall Street reversed into the red. Worries that the unrest in Libya could spread to other oil producing states worried investors. If one of the Middle Eastern producers had an interruption in supply we could see oil at over $200 a barrel, with a huge negative impact on global economic growth similar to the oil shock of the 1970's following the Arab-Israeli war.
The Contrarian Investor Uk portfolio had a good day with some good timing of trades. I ditched some Rockhopper positions early on whilst still up (finished down 5%) to increase my holding in Weatherly and Solomon Gold. Both were down in the morning but SOLG finished up 7.5% and WTI finished flat. At 12p Weatherly was a great top up opportunity despite the drop in the copper price today. Good to see Xcite staying in the blue, though off its best for the day.
On another note, Sareum Holdings finished down 13% after the 30%+ rise first thing (see my post earlier in the day). MeDaVinci changed its name to Orogen gold today and fell 8% to 0.87p as the new shares were issued to complete the purchase of its Serbian gold prospect.
The FTSE 100 is having a good day, up 42 to 6,033. The Dow Jones industrials are up 57 to 12,223.
Citigroup today increased its 2011 forecast for US light crude to $105 per barrel from $90 and their 2012 forecast is for at least $100 a barrel. Libya has lost about 1 million barrels of production since the civil war broke out. Tanker rates have surged 18 fold since the beginning of March as oil refiners try to stock up on crude supplies in anticipation of further issues in North Africa and the Middle East.
Unfortunately we are as addicted to oil as we ever were, particularly in the U.S. where fuel efficiency is still not on the agenda of many American motorists. $100 a barrel oil may make consumers think differently about the way they use oil, and in the case of the USA its about time. With petrol now at £6 a gallon in the UK, we are already paying the price of rising oil but also bloated taxes on the fuel.
Cancer drug development company, Sareum holdings (SAR) soared to 3.25p first thing this morning on hype about its new cancer development drug. The shares have risen almost three fold in the last few few days on a stampede into the shares. But unfortunately beyond the hype a few pieces of important information seem to have been.forgotten. The chk1 inhibitor for bowel cancer is in a preclinical phase and although at this very early stage, results have been.encouraging, ultimately 90% of new drugs don't make it to market because of safety or efficacy issues.
Also it will take 5 years at least for the drug to hit the market as they are years away from a regulatory submission. They have around a £1 million left in the bank, so a placing is likely as big drug companies will not pay a big upfront payment to Sareum until certain milestones have been met. Also the company will want to expoit its RNS to the full, and fill its coffers whilst it can. I can tell you that if a placing happens it won't be at 3p.
I see that sense has prevailed and the shares are now down 10%, after being up over 30% earlier. The smart money bolted when it hit 3p, and the poor private investors who believed the hype can now get 2.1p. A great "pump and dump" if i ever saw one! I hope too many new investors in AIM stocks haven't lost too much! Be careful out there, its a jungle!!
Xcite Energy is moving up nicely today to 350p to buy. What a bargain XEL was at 300p early last week. With reserves upgrade due in the next 2-3 weeks I think there will continue to be plenty of upside here.
Amazing that Weatherly Int. is down again today by 3%. Have topped up yet again and now holding a little too many for comfort. But when stock is drifting down like this its a good time to buy. Calling the bottom is an impossible task and 12p feels pretty comfortable. Same goes for Solomon Gold which is down to 27P to buy. When everyone else loses interest, this is the time to buy, not on the spikes when the momentum investors are back.
4th March 2011
The Manager
Company Announcements
Australian Securities Exchange Limited
Level 6, 20 Bridge Street
Sydney NSW 2000
By e-lodgement
RE: PRICE QUERY
I refer to your letter dated 3 March 2011 in relation to the recent change in
price of the Company's securities and respond as follows in line with the
numbers of your letter.
1. The Company is not aware of any information concerning it, that has not
been announced and which, if known, could be an explanation for recent
trading in the securities of the Company;
2. Not applicable;
3. Range recently announced a number of key milestones for the Company across
its development and exploration assets, including;
- the securing of the drilling rig for its Georgian exploration program;
- anticipated mobilisation of the Georgian drilling rig expected March
2011, and planned spudding in April 2011;
- commencement of drilling at the East Texas Cotton Valley Project; and
- successful fracture stimulation of the lower two zones on the Russell
Bevly well, with the upper two zones to follow later in March 2011.
It is anticipated that further updates on the Company's activities will be made
with respect of its assets over the coming weeks as events occur, as indicated
in the recent announcements from the Company.
The Company also notes that its Executive Directors have been in London on a
promotional visit, further increasing the awareness and activities of Range to
a wide range of the London investment community, at a time of increased
activity across the Company's portfolio of assets.
Since the release of the announcements referred above, the share price has
increased significantly (with volume) on its AIM traded shares (with ASX
following).
4. The Company confirms that it is in compliance with the ASX Listing Rules.
Yours faithfully
Peter Landau
Executive Director
Contacts
(AIM: SAR) 4 March 2011 SAREUM HOLDINGS PLC ("Sareum") Research Update: Positive Chk1 Programme Model Studies Sareum, the specialist cancer drug discovery business, is pleased to announce positive results from pre-clinical in-vivo efficacy studies from their joint research collaboration with Cancer Research Technology Limited ("CRT") and The Institute of Cancer Research ("The ICR"). A recent colon cancer pre-clinical model study carried out by The ICR demonstrates that the combination of a collaboration Chk1 inhibitor, dosed via the oral route, in combination with a chemotherapeutic, gemcitabine, demonstrates a greater than two-fold reduction in cancer growth rate compared to treatment with the same dose of gemcitabine without the Chk1 inhibitor. Further pre-clinical in-vivo studies for the programme show that the collaboration Chk1 inhibitor, dosed alone, can reduce cancer growth in models of AML (acute myeloid leukaemia) and neuroblastoma (a childhood cancer). Certain cancers, such as these, are believed to be dependent on Chk1 for survival. The joint research collaboration with the ICR and CTR targets Chk1 (Checkpoint Kinase 1). Chk1 is important in controlling a cancer cell's response to DNA damage, which may be a consequence of the cancer itself, or intentionally caused by chemotherapy or radiotherapy. Sareum's CEO, Dr Tim Mitchell, commented: "These are exciting advances, demonstrating efficacy of our Chk1 compounds in several cancer models. Studies on additional models are on-going. We believe the results from the recently conducted studies will significantly enhance the licencing package and assist the collaboration in selecting the best compound for development into a clinical trials candidate".
After briefly hitting close to £3 again this morning, Xcite Energy (XEL)
has finally rallied from its lows to rise as much as 19p to 323p (6%).
The shorters have been out in force over the last few days. They hunt in
packs using the bulletin boards to feed false rumours into the market. Supposed expert posters were questioning the work that Schlumberger had done on the flow test in December and whether the CPR would be delayed again because it hadn’t been done properly and the classic yesterday that
the oil actually wouldn’t flow because it was too viscous at ambient North
Sea temperatures. In other words, the drilling experts, Schlumberger had
been complete monkeys and made a hash of it.
Then there was the conspiracy theories that the board were keeping market
sensitive information to themselves and that the reserves upgrade would be
below expectations and that they had change supplier (to TRACS) to massage
the figures. Oh, I almost forgot the rumour that they were planning a
massively discounted rights issue at £2.50. All complete XXXX of course!
So the inexperienced investors think “oh, maybe the rumours are true, I’ll
sell at £3.00 and put my money into something else which is going up (e.g.
Range)”. Those posters on iii.co,uk and LSE boards must be “in the
know”. A classic Bear raid! Of course, by the time they’ve sold and moved
into something else, that's goes down as well. Get the weak to sell and the
shorters feed off the frenzy. When they’ve got their man, they switch and
start buying. Whilst the sheep were selling the last few days, I’ve been
topping up. Not putting up with any market maker or shorter nonsense! Hope
they’ve closed their shorts now!!?